Creatinine Clearance Cockcroft Gault Calculator
Estimate creatinine clearance for drug dosing using the Cockcroft-Gault equation. Enter values for instant results with step-by-step formulas.
Formula
CrCl (mL/min) = [(140 - Age) x Weight x (0.85 if female)] / (72 x Serum Creatinine)
Age in years, Weight in kg, Serum Creatinine in mg/dL. Multiply by 0.85 for female patients. The result estimates creatinine clearance in mL/min. Ideal body weight (Devine formula) should be considered for obese patients.
Worked Examples
Example 1: Standard Calculation for Male Patient
Problem: A 65-year-old male weighing 80 kg with a serum creatinine of 1.4 mg/dL. Calculate creatinine clearance using the Cockcroft-Gault equation.
Solution: CrCl = [(140 - 65) x 80 x 1.0] / (72 x 1.4)\nCrCl = [75 x 80] / 100.8\nCrCl = 6000 / 100.8\nCrCl = 59.5 mL/min\nFDA Category: Moderate Renal Impairment (CrCl 30-59)\nDrug doses renally cleared medications may need adjustment.
Result: CrCl: 59.5 mL/min (Moderate Impairment) - Check drug-specific dosing recommendations
Example 2: Obese Female Patient with Adjusted Weight
Problem: A 50-year-old female, height 165 cm, actual weight 110 kg, serum creatinine 0.9 mg/dL. Calculate CrCl using actual weight, ideal body weight, and adjusted body weight.
Solution: Height in inches: 165 / 2.54 = 64.96 in\nIBW = 45.5 + 2.3 x (64.96 - 60) = 45.5 + 11.4 = 56.9 kg\nABW = 56.9 + 0.4 x (110 - 56.9) = 56.9 + 21.2 = 78.1 kg\nActual weight: 110 kg > 1.2 x 56.9 (68.3 kg) = Obese\n\nCrCl (actual wt): [(140-50) x 110 x 0.85] / (72 x 0.9) = 130.0 mL/min\nCrCl (IBW): [(140-50) x 56.9 x 0.85] / (72 x 0.9) = 67.3 mL/min\nCrCl (ABW): [(140-50) x 78.1 x 0.85] / (72 x 0.9) = 92.3 mL/min
Result: CrCl: 92.3 mL/min (using ABW) vs 130.0 (actual) vs 67.3 (IBW) - Use ABW for obese patients
Frequently Asked Questions
What is the Cockcroft-Gault equation and why is it still used?
The Cockcroft-Gault equation was published by Donald Cockcroft and Henry Gault in 1976 as a method to estimate creatinine clearance (CrCl) from serum creatinine, age, weight, and sex. Despite being nearly five decades old, it remains one of the most widely used renal function estimators in clinical practice, particularly for drug dosing purposes. The majority of drug manufacturers conducted pharmacokinetic studies using Cockcroft-Gault to establish renal dosing recommendations in FDA-approved drug labels. This historical dependence means that using alternative equations like CKD-EPI for drug dosing may not accurately match the populations studied during drug development, potentially leading to incorrect dose adjustments.
How does the Cockcroft-Gault equation differ from the CKD-EPI equation?
The Cockcroft-Gault equation estimates creatinine clearance (CrCl), while the CKD-EPI equation estimates glomerular filtration rate (eGFR). Though related, these are different measurements. Creatinine clearance slightly overestimates true GFR because creatinine is both filtered by glomeruli and secreted by renal tubules. The Cockcroft-Gault equation incorporates actual body weight, while CKD-EPI normalizes to body surface area. CKD-EPI is recommended for CKD staging and diagnosis, while Cockcroft-Gault is preferred for drug dosing because most pharmaceutical dosing studies used it. The CKD-EPI equation was developed using more modern creatinine assays and a larger, more diverse study population.
When should ideal body weight versus actual body weight be used in the Cockcroft-Gault equation?
The original Cockcroft-Gault equation was developed using actual body weight, but this can significantly overestimate creatinine clearance in obese patients because excess adipose tissue does not proportionally increase creatinine production. For patients whose actual body weight exceeds their ideal body weight by more than 20 percent, many pharmacists and clinicians use adjusted body weight (ABW), calculated as ideal body weight plus 40 percent of the difference between actual and ideal weight. Some drug dosing references specify which weight to use. For underweight patients, actual body weight should generally be used. The choice of weight measure can result in clinically meaningful differences in calculated CrCl, potentially affecting drug dosing decisions.
What are the limitations of using serum creatinine to estimate kidney function?
Serum creatinine has several important limitations as a marker of kidney function. Creatinine production depends on muscle mass, so patients with reduced muscle mass (elderly, malnourished, amputees, cirrhotic) may have falsely low serum creatinine levels that overestimate their true kidney function. Conversely, very muscular individuals may have elevated serum creatinine without actual kidney impairment. Creatinine levels do not rise above the normal range until approximately 50 percent of kidney function is lost, creating a diagnostic blind spot for early kidney disease. Certain medications (trimethoprim, cimetidine) inhibit tubular secretion of creatinine, raising serum levels without affecting true GFR. Diet can also affect creatinine levels, particularly high meat intake.
How do FDA drug dosing categories correspond to Cockcroft-Gault creatinine clearance values?
The FDA established standardized renal function categories for drug dosing based on Cockcroft-Gault estimated creatinine clearance. Normal renal function is defined as CrCl of 90 mL/min or higher. Mild renal impairment corresponds to CrCl of 60 to 89 mL/min. Moderate renal impairment is CrCl 30 to 59 mL/min. Severe renal impairment is CrCl 15 to 29 mL/min. End-stage renal disease is CrCl below 15 mL/min or requiring dialysis. These categories are used in drug package inserts to provide dosing recommendations. Clinicians should check the specific drug labeling, as some medications use different cutoffs or different renal function equations for their dosing recommendations.
How does age affect the Cockcroft-Gault calculation and its clinical implications?
Age is a critical variable in the Cockcroft-Gault equation, appearing in the numerator as (140 minus age). This reflects the well-established physiological decline in kidney function with aging, estimated at approximately 1 mL/min per year of GFR decline after age 30 to 40. The equation predicts that creatinine clearance decreases linearly with age, independent of other factors. However, this age-related decline occurs simultaneously with age-related loss of muscle mass, which reduces creatinine production and can mask the decline in serum creatinine levels. This means that an elderly patient with a normal serum creatinine may still have significantly impaired kidney function. The Cockcroft-Gault equation accounts for this phenomenon better than relying on serum creatinine alone.